Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: Outcomes of general anesthesia versus conscious sedation for Stroke undergoing endovascular treatment: a meta-analysis

Author

Study design

Study Period

Country

Inclusion Criteria

Exclusion Criteria

Outcomes

Type of Endovascular Treatment

Sample Size (GA/CS)

Methodological qualitya

Abou-Chebl et al. (2010)

Retrospective cohort study

2005–2009

USA

Anterior circulation AIS

Posterior circulation strokes; no intervention was performed

mRS and mortality on day 90

IA/IV tPA, mechanical thrombectomy, angioplasty

428/552

5

Jumaa et al. (2010)

Retrospective cohort study

2006–2009

USA

Middle cerebral artery–M1 segment occlusion treated with endovascular therapy

Vertebrobasilar occlusions; internal carotid artery terminus occlusion; M2 occlusion

mRS and mortality on day 90

IA/IV tPA and mechanical thrombectomy

53/73

7

Nichols et al. (2010)

Post hoc analysis of IMS II trial

NA

USA

Anterior circulation strokes and underwent angiography and/or intervention

Data were not available before or after angiography

Recanalization, mRS and mortality on day 90

IA/IV tPA, low-energy ultrasound

26/49

7

Sugg et al. (2010)

Retrospective cohort study

2007–2009

USA

AIS and underwent endovascular treatment within 8 h from symptom onset

NA

Recanalization, mRS and mortality on day 90

Mechanical thrombectomy

9/57

5

Davis et al. (2012)

Retrospective cohort study

2003–2009

Canada

AIS and received endovascular treatment

Management could not be determined

mRS and mortality on day 90

IA tPA and mechanical thrombectomy

48/48

7

Hassan et al. (2012)

Retrospective cohort study

2006–2010

USA

AIS and received endovascular treatment

The infarct burden was greater than or equal to one third of the middle cerebral artery territory

mRS and in-hospital mortality

IV tPA, endovascular technique not specified

53/83

5

Langner et al. (2013)

Retrospective cohort study

2005–2010

Germany

AIS and treated with endovascular therapy

NA

mRS and mortality

IA tPA and mechanical thrombectomy

19/105

8

Abou-Chebl et al. (2014)

Post hoc analysis of NASA registry

NA

North America

AIS and received endovascular treatment within 6 h from symptom onset

NA

mRS and mortality on day 90

IV tPA, mechanical thrombectomy

196/85

7

John, S et al. (2014)

Retrospective cohort study

2008–2012

USA

Anterior circulation AIS and treated with endovascular therapy

Posterior circulation AIS

In-hospital mortality and mRS on day 30

IV tPA, mechanical thrombectomy

91/99

9

Li et al. (2014)

Retrospective cohort study

2006–2012

USA

AIS and received endovascular treatment

NA

mRS and mortality

IA tPA, mechanical thrombectomy

35/74

8

Abou-Chebl et al. (2015)

Post hoc analysis of IMS III trial

2006–2011

USA

AIS, received IV tPA within 3 h and received endovascular treatment

Large regions of clear hypodensity on CT scan

mRS and in-hospital mortality

IV/IA tPA and mechanical thrombectomy

147/269

9

McDonald J.S et al. (2015)

Retrospective cohort study

2006–2013

USA

AIS and received mechanical thrombectomy

Patients who underwent another invasive surgery

In-hospital mortality and complications

IV tPA and mechanical thrombectomy

507/507

7

Van Den Berg L.A. et al. (2015)

Retrospective cohort study

2002–2013

Netherlands

Anterior circulation AIS

Patients lack of information

mRS and mortality

IA tPA and mechanical thrombectomy

70/278

7

Just, C. et al. (2016)

Retrospective cohort study

2000–2013

Canada

Underwent neuro-interventional stroke procedure

Aneurysm repair, carotid stenting, extracranial-intracranial bypass

mRS and mortality on day 90 and 180

IA tPA and mechanical thrombectomy, thromboaspiration

42/67

8

Berkhemer OA. et al. (2016)

Post hoc analysis of MR CLEAN

2010–2014

Netherlands

AIS patients who received mechanical thrombectomy or intra-arterial thrombolysis

Cerebral hemorrhage, coagulation abnormalities

mRS and mortality on day 90 and 180

IA tPA and mechanical thrombectomy, thromboaspiration

79/137

9

Schönenberger S et al. (2016)

RCT

2014–2016

Germany

Severe AIS, NIHSS> 10

diagnostic imaging results did not clearly depict site of vessel occlusion

NIHSS after 24 h, mRS and mortality on day 90

IA tPA and angioplasty, mechanical thrombectomy, thromboaspiration

73/77

NA

Bekelis, K. et al. (2017)

Retrospective cohort study

2009–2013

USA

AIS patients undergoing mechanical thrombectomy

NA

mortality in hospital

IV tPA, thromboaspiration

441/733

6

Lowhagen Henden, P. et al. (2017)

RCT

2013–2016

Sweden

Anterior circulation AIS, NIHSS> 10

Occlusion of posterior cerebral circulation

mRS and mortality on day 90 and 180

IV tPA, mechanical thrombectomy

45/45

NA

Slezak, A.et al. (2017)

Prospective study

2010–2015

Switzerland

Anterior circulation AIS

NA

mRS and mortality on day 90

IV tPA, mechanical thrombectomy

266/135

7

Simonsen, C. Z. et al. (2018)

RCT

2015–2017

Denmark

Anterior circulation AIS

Glasgow Coma Scale score < 9 or premorbid mRS score > 2

mRS and mortality on day 90 and 180

IA tPA, angioplasty, mechanical thrombectomy

65/63

NA

Peng et al. (2018)

Prospective study

2015.01–2015.08

China

Anterior circulation AIS

DWI lesion volume > 50 mL

Rates of successful recanalization and mRS on day 90

Interventional treatment with Solitaire

44/105

8

Omer F. Eker et al. (2018)

Post hoc analysis SWIFT PRIME trial

2013–2015

USA and Europe

Anterior circulation AIS

Subject who is contraindicated to IV t-PA

Rates of successful recanalization and mRS on day 90

Teated with Solitaire RevascularizationDevice and IV-tPA

32/65

8

Shanet et al. (2018)

Retrospective cohort study

2014–2016

China

Anterior circulation AIS

Received intra-arterial thrombolysis alone, with concomitant aneurysm or arteriovenous malformation

mRS and mortality on day 90

NA

114/114

8

  1. aNewcastle Ottawa scale was designed to assess the quality of non-randomized studies. GA general anesthesia, CS conscious sedation, AIS acute ischemic stroke, IA intra-arterial, IV intra-venous, tPA tissue plasminogen activator, mRS modified Rankin Score, NA not available, RCT randomized controlled trial, NIHSS National Institute of Health Stroke Scale